|
|
Article: Asterand and BioWisdom Announce Agreement to Integrate Asterand's Quantitative Human Gene Expression Database with BioWisdom's Integrated Discovery Platform.
- Article from:
- Business Wire
- Article date:
- February 9, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DETROIT -- Asterand plc (LSE: ATD), a leading provider of human tissue and services to pharmaceutical companies engaged in drug discovery research, and BioWisdom Ltd, a market leader in delivering healthcare intelligence to the pharmaceutical industry, announce that the Companies have entered into a data syndication agreement to provide value added delivery of Asterand's human gene expression profiles through BioWisdom's intelligence solutions. Terms of the agreement were not disclosed.
Through this agreement, BioWisdom gains access to the data within Asterand's proprietary Target Evaluator[TM] database. The database consists of quantitative human gene expression ...